The HILPDA protein: A potential biomarker for new treatment options in aggressive kidney cancer

A new study from Karolinska Institutet discovered that blocking the MYC tumor protein in kidney cancer cells leads to an increase in fat droplets, which are associated with tumor growth. The study, published in Proceedings of the National Academy of Sciences, provides crucial knowledge for identifying new therapeutic targets for treating this aggressive form of cancer.

Leave A Comment

Your email address will not be published. Required fields are marked *